Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No connection to AMD microprocessors either.
A possible connection to elves at the North Pole though, if you require no evidence or proof with your DD.
No connection whatsoever to Radient.
As usual.
Being an AZBio board member allows you to give a sales pitch at the annual conference disguised as a scientific presentation.
But is GCDx funded? No it is not.
Does GCDx have a manufacturing facility? No they do not.
Does GCDx have a bricks-and-mortar office? Not in Suite 105 they don't -- so why not update their website to tell us where it moved?
I don't place much value in AZBio's "Gold level member" rating. What does that mean?
Gartner is a board member on AZBio. Does that automatically give him a gold level member rating?
AZBio let Gartner give a sales pitch disguised as a presentation at their conference last year. If I were in that audience, I'd be annoyed by that sales pitch. You get sales pitches from vendors out in the hallways and at their booths, not in scientific presentations.
Facts:
* Nobody can find a physical address for GCDx.
* GCDx is not selling anything.
* GCDx does not answer their phone, listen to voice messages, or answer emails.
* There is no evidence that GCDX has a license to manufacture or sell DR-70 or onko-sure.
interesting, blackpantherz.
what has this got to do with RXPC?
Yes, the oncology community keeps working on cancer -- but is it good news for this stock if they do it without incorporating DR-70 in any way?
A website copyright means the GoDaddy website is current and operational.
It doesn't mean GCDx exists beyond that website.
I have a GoDaddy website for a small business I occasionally operate. I did nothing with that business in 2013 and might not do anything in 2014. I still pay $5.99 per month to keep the website up, though, and I renew the domain name whenever it is about to expire.
Why doesn't GCDx answer their phone and/or check their voice messages? Why don't they answer emails? Why aren't they selling anything? Why does the website list only two employees -- Gartner and Baker -- and why did Baker post her resume online right after funding fell through in 2012?
Where is GCDx located physically? It's not in Suite 105 anymore -- why not update the website with the current address, if there IS a current physical location?
Face it. GCDx and RXPC are shells that currently exist on paper only. If you disagree, offer proof to the contrary.
My description is 100% accurate.
I encourage everyone to visit that biography on Gartner and decide for yourselves who is correct. Consider the following:
* Gartner got a "Fast Lane Award" for GCDx in 2012. Unfortunately, he didn't have funding when he got that award, and he never got funding. GCDx is NOT in the Fast Lane anymore -- it's not even on the road.
* The picture shows Gartner in his 50's. He's 72 years old now.
* That bio doesn't mention anything Gartner has done since 2012. Why not? Answer: he has done nothing since 2012, other than deliver a sales pitch at AZBio that failed, and try to raise money on Fundable.com, only to fail there too.
Did you notice that AZBio is not letting Gartner give another sales pitch this year?
search the Arizona Star for "Global Cancer Diagnostics." Not there.
http://yellowpages.azstarnet.com/tempe+az/global+cancer+diagnostics/distance.30.n.all-31.zq.html
Search everywhere you can think of -- the only place you will find any evidence that GCDx exists is on their GoDaddy website.
Face it: Radient and GCDx both exist only on paper. Neither is operational.
whitepages says there are no current residents at 2343 W University Dr, Suite 105.
http://www.whitepages.com/search/FindNearby?utf8=%E2%9C%93&street=2343+W+University+Dr+Ste+105&where=Tempe%2C+AZ
Aspen Technologies (cable splicing company) was there more recently than Gartner, but Aspen moved.
Call the number for GCDx -- nobody will answer, and the voice message mailbox is full so you can't leave a message. Send GCDx an email. They will not respond.
I think the "clandestime location" for Radient Pharmaceuticals is a file box in MacLellan's basement.
Gartner has a mailing address in Arizona and a GoDaddy website.
Anything else is speculation.
Nobody answers the phone at the number listed on the website and nobody responds to emails on the website.
Top Penny was talking about a different stock: ATYG
Radient is not active. Do not believe the nonsense you have been hearing lately to the contrary.
Gartner never said or hinted that he was interested in acquiring RXPC. Gartner tried to license DR-70 in 2012 and failed to get funding. He may be still trying -- but all he wants to do is license DR-70, not acquire RXPC.
ATYG might have an operating facility....
but RXPC does not.
You're mixing up two message boards, aren't you? You don't really think Radient has an operating facility, do you?
Their facility has been available for lease for months. Radient does not currently have office space or a facility. You know they always rented that space and never owned it, right?
They also let their European patent application expire, and they let their FDA clearance expire. DR-70 / onko-sure is not currently FDA cleared for anything -- not even CRC monitoring.
I've done my homework.
Radient's facility has been for lease since November 2013.
http://www.loopnet.com/xnet/mainsite/listing/Profile/Profile.aspx?LID=18217398&PreviousLinkCode=10850&PreviousSourceCode=1lww2t006a00001&FromListingProfilePage=true&PgCxtGuid=9b96fa23-768e-4d3a-af9a-b627ca1ae5da&PgCxtFLKey=ProfileSE&PgCxtCurFLKey=&SeqNum=1&PgCxtDir=Up&EBroker=lakeshore555%40yahoo.com&LinkCode=10850&SourceCode=1lww2t006a00001
How are they staffing it three days a week if they are no longer tenants?
Prove it.
What is the address of the facility? What's the phone number? What proof do you have that it is staffed, three days pewr week or three days per year?
It's not operational. Hasn't been for many months. Radient has no money to pay employees.
The facility is staffed three days per week?
Prove it.
What is the address of this "facility" to which you refer?
No the facility is NOT still open.
The space is up for lease. Nobody is leasing it now.
Radient is licensing the rights to manufacture to anyone who will pay $100,000 annually. MacLellan OBVIOUSLY has no intention of manufacturing DR-70 now or in the future.
Their facility is not open and operational.
This has been verified by more than one person who visited the facility.
Faith defined:
Strong belief in God or in the doctrines of a religion, based on spiritual apprehension rather than proof.
Sounds about right.
Their facility is NOT open and operational and has not been open or operational for some time.
Ludacris is a rapper. I think you meant "ludicrous."
What does ATYG stand for?
considering how little we really knew about the company's financial problems in March 2011, I think Gold Seeker did an amazing job of analyzing this company.
in hindsight, isn't it now obvious that the stock was kept alive by misleading press releases and bloggers? The $10 million India Order, the Mayo Study, Claiming Jade was worth $20 million on the books, promises of "monetizing" Jade and NuVax..... all false.
And isn't it obvious that when Jade "blew up" on Radient, that was the beginning of the end? The one profitable quarter for this company came in 2008 from Jade Revenues. After Radient lost Jade in 2009, they not only never came close to being profitable again, but they had to borrow money at usurious rates, and subsequently defaulted on every one of those loans.
what is overdue?
if you're referring to a takeover -- that was proven to be myth when it didn't happen in 2011.
Dougie Mac hasn't had any money for PR's since 2011.
Why would anyone think that shares of a zombie pinksheet stock are "locked up."
Waiting for evidence that CIT is being used anywhere for anything, research or otherwise.
Interested to know whether the statement "CIT seems to weave its way into a lot of various research" is anything more than..... well you know.
Thanks in advance.
here is a link to your "CIT Reference:"
http://www.google.com/patents/WO2013185032A1?cl=en
CIT has nothing to do with that patent, its inventors, or Harvard.
This is reminiscent of the false Pfizer/Radient link you posted a month ago. Did you notice that GlaxoSmithKline and Pfizer are also mentioned in the patent application you're citing?
Yes, DR-70 gets used in research. Unfortunately, there's little profit in that.
But CIT doesn't "weave its way" into research or anything else, to my knowledge. Please provide evidence that CIT is being used anywhere, by anyone. Thanks in advance.
Why does anything have to happen here?
Eventually the patents will get approved or denied, but it won't matter much, either way. A patent for a motorized Q-tip isn't worth anything if nobody wants to buy a motorized Q-tip.
I was a member of several Class Actions from 1999 and 2000. Most of the awards were so small I didn't bother sending in the paperwork. But it is ALWAYS cash, and nothing else. And they weren't distributed until 2006 or later.
In a class action award, it is a monetary settlement. The lawyer gets a lion's share. The lead plaintiffs are next in line. The other Class Members are last. They will get a pittance.
Those are the terms. There's nothing complicated about a Class Action Award. It's Cash Only. No shares, no certificates, no coffee mugs with Radient written on the side, no "Rear in Gear" t-shirts, no office equipment: just a lump sum of cash to be distributed.
And if there is no insurance to cover the award, nobody will get anything in this case. Will Rosen try to force bankruptcy in that event? Doubtful, it's just throwing good money after bad. If a court forced Radient into BK, the Administrator would get a few hundred thousand MAYBE for intellectual property, tops (probably a lot less), and the lenders would all make claims. What a mess that would be. Rosen would probably get nothing.
takeover advocates: explain this.
I see 500,000 shares on the Ask for .0001. I could buy 500,000 shares right now for $50.
Then after the takeover, the PPS is going how high? a dime?
So my 500,000 shares would then be worth $50,000?
If that is true, why isn't the takeover group buying every available share? Money is money. That is an insane profit -- a once-in-a-lifetime profit -- and the insiders of the takeover group know it's coming.
But nobody is buying.
Makes no sense. Even if the PPS goes to a penny... If someone knew for sure that a takeover was happening, and they thought the PPS was going to even .001, they would buy every available share at anything under .0005. Everyone is greedy when a sure thing stares them in the face.
So why is this buying not happening? Thanks for explaining.
Unsubstantiated opinion.
Nothing is "evident." For example: Rosen may have settled because he knew there was no money, so he decided not to spend any more time or resources going to court.
When Rosen started the class action, Radient appeared to have money. Of course that was an illusion, but as the truth came to light gradually over 30 months, what were Rosen's options? Just shrug and walk away?
Insurance may have paid for the lawyers but not for the award.
Class Members will learn if there was any money retrieved. They will get a letter explaining how much they got. I hope one of the Class Members posts that information when that letter arrives.
If there is an award distributed, of course it is cash. What else would it be? SHARES OF A DEAD COMPANY? The last thing the plaintiffs and/or Rosen want is RXPC shares. The last thing ANYONE wants is RXPC shares.
As for "deep pocketed investors" -- there are none. There is no apple cart. There are no apples. And RXPC is not going to issue "news" about the case. They might file an 8-K and they might not. But they are not going to issue "news." They haven't issued "news" since 2011.
What would Radient gain from issuing "news?" They will never get another loan, they burned up their A/S so they can't issue shares -- they don't have a building, or a manufacturing facility, or a parking space in a parking lot. MacLellan has no motive to do ANYTHING with Radient now. Even Boswell left.
If nobody is going to force MacLellan to file for bankruptcy, this is it: crickets and tumbleweeds. Maybe, just MAYBE, Gartner might come up with funding for GCDx -- so unlikely it's barely worth discussing, but it's possible I guess -- but that won't help Radient. Neither will the UNI Agreement. $100,000 per year from UNI pays for little.
We all know the creeping takeover is myth.
But it is fun to debate. Especially since all the evidence and logic is on the "no takeover" side -- it is fun to listen to someone try to defend the "yes takeover" position.
I think we have to assume that insurance paid for the settlement. If not, there is no settlement, because Radient can't pay even 10% of $2.5 million. There's no reason to think they paid the $900,000 in unpaid bills disclosed in December 2011.... In fact there's no reason to think they ever paid Mayo.
Where DID all that money go? The first set of financing was to pay off the previous defaulted loans, but the second round of financing was supposed to pay for a lot of things that never happened.
I still do not understand who is footing that bill.
Radient doesn't have 2 dollars and 50 cents, let alone $2.5 million.
We are all assuming that insurance is paying for it. Wish there was some way of knowing for certain.
Well anyway, the Class Action is over. Time for that Creeping Takeover Group to step up to the plate and take proud ownership of this gem.
Unless of course they are now going to wait for the patents. Interest on the defaulted loans accrues at the rates of $$ millions annually, but money is no object to this Takeover Group. They have lost $$$ millions already on accrued interest to maintain their secrecy..... what's a few $$$ million more as they wait for the golden patents.
Meanwhile, JnJ marches ahead with their CTC blood test which, when available, will turn onko-sure revenues from slim to none. This is the future of cancer screening:
http://www.massgeneral.org/cancer/news/ctc.aspx
It's the future because JnJ is behind it and they will squash all other cancer blood screeners like gnats. That's how the Pharma Industry works. The longer the Creeping Takeover group waits, the narrower their window gets for making a profit on onko-sure.
I'm being sarcastic, of course. There is no takeover group. No merger, no buyout, no takeover. Silly to even discuss it, but, Radient has no other hope, so, we discuss.....
Everyone has their own investment style.
Some, for example, buy a stock without doing their own DD, and then hold it for 2.5 years while it falls from $29 PPS (split-adjusted) to 0.0001 PPS -- and then refuse to buy more at .0001.
I have trouble calling that strategy "professional." If I thought there was really a buyout here -- even a CHANCE of a buyout -- I'd buy all I could buy at .0001.
I guess that makes me an amateur.
let's put it another way.
IF there really was a creeping takeover group.... and there was 500,000 shares on the ASK for $0.0001.... the creeping takeover group has two choices:
A. Buy those shares right now for $50 and retire them.
B. Wait until after the takeover, and pay that shareholder $50,000 or $500,000 for them.
A is not happening -- shares sit on the Ask. B is silly.
The fact that A does not happen is proof that there IS NO TAKEOVER. End of story. Seriously.
look for RXPC to make EXAS look like a penny stock in comparison?
Really? EXAS trades on NASDAQcm and trades for $11 PPS. What is your prediction for RXPC? And when will this happen?
And Existing Investors are "all in?" You think RXPC is going to increase from .0001 to a dime or dollar or whatever, but Existing Investors don't want any more?
500,000 on the ask at .0001 and Existign Investors think that will turn into $500,000 "any day now," but that's not good enough?
EXAS is similar to RXPC?
EXAS was delisted to the pinksheets, named in a class action, failed to repay every loan they ever took out, had an FDA-cleared test that failed to generate even 5% of the revenues needed to break even with operational costs, increased their AS to 5 billion, and then diluted to 4.5 billion OS?
BRAAAAAAINS!
You are probably right, Jim.
Yes, the buyout/merger is a fable, but BK appears to be the same.
This company looks like it will limp along forever, never operating again, never reporting financials to the SEC again, never doing ANYTHING except maybe selling a license agreement here and there.
I've seen good companies file for bankruptcy while they still had shareholder equity and I've seen bad companies like Radient stagger on forever. Makes you wonder.
Update on Class Action court page. Continued to 12/31/2013, boring but I thought I'd share anyway. Settlement appears on track.
http://www.plainsite.org/flashlight/case.html?id=1504670
121 Filed: 11/29/2013, Entered: None
STIPULATION to Continue Pretrial Conference and Trial from December 3, 2013 8:30 am to two weeks, to allow for filing fo settlement documents Re: Minutes of In Chambers Order/Directive - no proceeding held, Set/Reset Hearing,, 120 filed by plaintiffs Quintana Group. (Attachments: # 1 Proposed Order, # 2 Declaration of Laurence Rosen)(Rosen, Laurence) (Entered: 11/29/2013)
122 Filed: 12/2/2013, Entered: None
ORDER by Judge David O. Carter, granting Stipulation to Continue, 121 . ( Pretrial Conference continued to 12/31/2013 08:30 AM before Judge David O. Carter.) (twdb) (Entered: 12/02/2013)